Ascendis Pharma Ownership | Who Owns Ascendis Pharma?

Ascendis Pharma Ownership Summary

Ascendis Pharma is owned by 37.10% institutional investors, 0.76% insiders, and 62.14% retail investors. Ra capital management is the largest institutional shareholder, holding 17.01% of ASND shares. MFS Mid Cap Growth Equity is the top mutual fund, with 2.08% of its assets in Ascendis Pharma shares.

ASND Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ascendis Pharma	37.10%	0.76%	62.14%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	10.28M	17.01%	$2.04B
Westfield capital management co lp	5.19M	8.50%	$1.11B
Avoro capital advisors	5.11M	8.45%	$1.02B
Janus henderson group	4.38M	7.64%	$602.91M
Fmr	4.47M	7.40%	$889.03M
Lombard odier asset management (europe)	4.27M	7.06%	$5.83M
Artisan partners limited partnership	3.72M	6.15%	$739.75M
Capital investors	3.06M	5.02%	$653.36M
T. rowe price investment management	2.67M	4.41%	$530.15M
Franklin resources	1.91M	3.13%	$407.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Q global advisors	170.00K	53.09%	$33.80M
Ra capital management	10.28M	25.19%	$2.04B
Resolute capital asset partners	165.67K	17.23%	$32.94M
Avoro capital advisors	5.11M	13.13%	$1.02B
Tri locum partners lp	174.83K	7.99%	$34.76M
Perceptive advisors	1.09M	6.25%	$216.40M
Ally bridge group (ny)	51.08K	6.18%	$10.16M
Great point partners	75.00K	6.15%	$14.91M
Vestal point capital, lp	600.00K	5.39%	$119.29M
Catalio capital management, lp	144.95K	5.33%	$28.82M

Top Buyers

Holder	Shares	% Assets	Change
Lombard odier asset management (europe)	4.27M	0.29%	4.27M
Wellington management group llp	1.80M	0.06%	880.84K
Vestal point capital, lp	600.00K	5.39%	400.00K
Spyglass capital management	388.65K	4.12%	388.65K
Franklin resources	1.91M	0.10%	320.12K

Top Sellers

Holder	Shares	% Assets	Change
T. rowe price investment management	2.67M	0.32%	-916.93K
Sofinnova investments	-	-	-734.28K
Paradigm biocapital advisors lp	-	-	-664.31K
Point72 asset management	-	-	-569.15K
Timessquare capital management	-	-	-500.92K

New Positions

Holder	Shares	% Assets	Change	Value
Lombard odier asset management (europe)	4.27M	0.29%	4.27M	$5.83M
Spyglass capital management	388.65K	4.12%	388.65K	$77.27M
Imc-chicago	113.68K	0.01%	113.68K	$24.24M
1832 asset management	110.00K	0.02%	110.00K	$21.87M
Artal group	101.10K	0.35%	101.10K	$13.79M

Sold Out

Holder	Change
Rakuten securities	-1.00
Kilter group	-1.00
Transamerica financial advisors	-1.00
Org partners	-6.00
Mai capital management	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	209	-31.25%	22,626,743	-66.96%	37	0.29%	122	-26.06%	53	-43.62%
Sep 30, 2025	291	15.48%	67,939,274	10.42%	112	1.07%	162	26.56%	88	4.76%
Jun 30, 2025	259	1.57%	63,281,991	-3.50%	105	0.88%	128	-0.78%	87	-2.25%
Mar 31, 2025	32	-85.71%	17,493,613	-72.74%	29	0.23%	16	-87.20%	9	-85.94%
Dec 31, 2024	221	-5.96%	64,027,760	1.63%	111	0.93%	123	0.82%	64	-7.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
MFS Mid Cap Growth Equity	1.28M	2.08%	-
MFS Mid Cap Growth A	1.28M	2.08%	722.55K
Capital Group Growth Fnd of Amer Comp	1.21M	1.97%	147.54K
American Funds Growth Fund of Amer A	1.21M	1.97%	147.54K
Vanguard Health Care Inv	1.10M	1.80%	-
Franklin DynaTech Fund A	1.00M	1.63%	-
Franklin Innovation Composite	1.00M	1.63%	400.00K
Janus Henderson Mid Cap Growth MA	976.88K	1.59%	976.88K
T. Rowe Price Mid-Cap Growth	784.10K	1.28%	-230.30K
T. Rowe Price US Mid-Cap Growth Equity	784.10K	1.28%	-231.30K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-

ASND Ownership FAQ

Who Owns Ascendis Pharma?

Ascendis Pharma shareholders are primarily institutional investors at 37.10%, followed by 0.76% insiders and 62.14% retail investors. The average institutional ownership in Ascendis Pharma's industry, Biotech Stocks , is 382.13%, which Ascendis Pharma falls below.

Who owns the most shares of Ascendis Pharma?

Ascendis Pharma’s largest shareholders are Ra capital management (10.28M shares, 17.01%), Westfield capital management co lp (5.19M shares, 8.50%), and Avoro capital advisors (5.11M shares, 8.45%). Together, they hold 33.96% of Ascendis Pharma’s total shares outstanding.

Does Blackrock own Ascendis Pharma?

BlackRock is not among the top 10 institutional shareholders of Ascendis Pharma.

Who is Ascendis Pharma’s biggest shareholder by percentage of total assets invested?

Q global advisors is Ascendis Pharma’s biggest shareholder by percentage of total assets invested, with 53.09% of its assets in 170K Ascendis Pharma shares, valued at 33.8M$.

Who is the top mutual fund holder of Ascendis Pharma shares?

MFS Mid Cap Growth Equity is the top mutual fund holder of Ascendis Pharma shares, with 2.08% of its total shares outstanding invested in 1.28M Ascendis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools